Get the Stockscreener App
1.28
1.59%
0.02
Pre-market:
1.31
0.03
+2.34%
Milestone Pharmaceuticals Inc Stock (MIST) Forecast
The Milestone Pharmaceuticals Inc (MIST) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.61, representing a +806.71% increase from the current price of $1.28. The highest analyst price target is $11.90, and the lowest is $11.31.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MIST Price Target
Average 7.5711
(+491.50% Upside)
Is Milestone Pharmaceuticals Inc (MIST) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.16 | Neutral |
| STOCH(9,6) | 92.92 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.1124 | Buy |
| ADX(14) | 21.18 | Neutral |
| William %R | -5.7587 | Sell |
| CCI(14) | 79.66 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9913
Buy
|
1.0655
Buy
|
| MA20 |
0.8705
Buy
|
1.1033
Buy
|
| MA50 |
1.537
Sell
|
1.3929
Sell
|
| MA100 |
1.7701
Sell
|
1.5789
Sell
|
| MA200 |
1.6491
Sell
|
1.6536
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, MIST could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on MIST, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 54.16 indicates that MIST is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 92.92 indicates that MIST is oversold. This means that MIST price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that MIST is oversold. This suggests that MIST price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.18 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 79.66 indicates that MIST is still overbought but not to an extreme extent.
Long-term MIST price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Milestone Pharmaceuticals Inc financial reports and earnings history, Milestone Pharmaceuticals Inc (MIST) stock could reach $13.03 by 2030, $10.17 by 2040 and $35.47 by 2050. See the projected annual prices until 2050 of the Milestone Pharmaceuticals Inc stock below:
- Milestone Pharmaceuticals Inc (MIST) is expected to reach an average price of $3.0017 in 2035, with a high prediction of $3.5783 and a low estimate of $3.335. This indicates an $134.51% rise from the last recorded price of $1.28.
- Milestone Pharmaceuticals Inc (MIST) stock is projected to chart a bullish course in 2040, with an average price target of $10.20, representing an $696.61% surge from its current level. The forecast ranges from a conservative $10.24 to a sky-high $10.17.
- Our analysts predict Milestone Pharmaceuticals Inc (MIST) to jump 1,122% by 2045, soaring from $16.69 to an average price of $15.64, potentially reaching $16.05. While $16.69 is the low estimate, the potential upside is significant.
- Milestone Pharmaceuticals Inc (MIST) stock is expected to climb by 2050, reaching an average of $34.36, a $2,584% jump from its current level. However, a wide range of estimates exists, with high and low targets of $35.47 and $35.17, respectively, highlighting the market's uncertainty.
Milestone Pharmaceuticals Inc Stock (MIST) Year by Year Forecast
Milestone Pharmaceuticals Inc Stock (MIST) Price Forecast for 2025
Milestone Pharmaceuticals Inc Stock (MIST) is expected to reach an average price of $5.963 in 2025, with a high prediction of $11.90 and a low estimate of $0.0288. This indicates an +365.86% rise from the last recorded price of $1.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $11.28 | $11.31 | $11.90 | +781.62% |
| June, 2025 | $10.24 | $10.45 | $10.47 | +700.11% |
| July, 2025 | $8.7773 | $9.3231 | $9.7707 | +585.72% |
| August, 2025 | $9.254 | $9.2964 | $9.0848 | +622.97% |
| September, 2025 | $2.9007 | $4.1007 | $9.1732 | +126.62% |
| October, 2025 | $4.7366 | $4.5199 | $4.6774 | +270.04% |
| November, 2025 | $4.9633 | $4.4849 | $4.5633 | +287.76% |
| December, 2025 | $6.2691 | $5.3208 | $5.9391 | +389.78% |
Milestone Pharmaceuticals Inc Stock (MIST) Price Forecast for 2026
The predicted value for Milestone Pharmaceuticals Inc (MIST) in 2026 is set at an average of $4.3617. Estimates vary from a peak of $5.4783 to a trough of $3.2451, indicating an +240.76% surge from the present price of $1.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.2459 | $5.3459 | $5.4783 | +309.83% |
| February, 2026 | $4.7426 | $4.9734 | $5.025 | +270.51% |
| March, 2026 | $4.3993 | $4.7243 | $4.5217 | +243.69% |
| April, 2026 | $3.1151 | $3.2451 | $3.6384 | +143.37% |
| May, 2026 | $3.9118 | $4.1094 | $3.3927 | +205.61% |
| June, 2026 | $5.1285 | $4.901 | $4.6752 | +300.67% |
| July, 2026 | $4.9544 | $4.9061 | $5.0577 | +287.06% |
| August, 2026 | $4.7811 | $4.9028 | $4.6436 | +273.53% |
| September, 2026 | $4.577 | $4.4495 | $4.267 | +257.58% |
| October, 2026 | $4.3137 | $4.5437 | $4.2454 | +237.01% |
| November, 2026 | $3.5704 | $3.6303 | $4.3029 | +178.94% |
| December, 2026 | $3.6863 | $3.5896 | $3.6371 | +187.99% |
Milestone Pharmaceuticals Inc Stock (MIST) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Milestone Pharmaceuticals Inc (MIST) is $1.8499, with a high forecast of $3.6055 and a low forecast of $0.0943. This indicates an +44.52% increase from the last price of $1.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.628 | $3.683 | $3.6055 | +183.44% |
| February, 2027 | $2.9197 | $3.2197 | $3.3822 | +128.10% |
| March, 2027 | $2.2656 | $3.0856 | $2.9472 | +77.00% |
| April, 2027 | $0.2823 | $1.8423 | $1.2946 | -77.95% |
| May, 2027 | $1.729 | $1.6098 | $1.399 | +35.08% |
| June, 2027 | $3.3149 | $2.1882 | $3.0107 | +158.98% |
| July, 2027 | $1.4416 | $1.8316 | $2.8141 | +12.62% |
| August, 2027 | $0.5583 | $1.0833 | $0.8858 | -56.38% |
| September, 2027 | $1.5242 | $1.2575 | $1.825 | +19.08% |
| October, 2027 | $1.4009 | $1.9017 | $1.5375 | +9.44% |
| November, 2027 | $0.7576 | $1.1884 | $0.9784 | -40.81% |
| December, 2027 | $0.3365 | $0.0943 | $0.7149 | -73.71% |
Milestone Pharmaceuticals Inc Stock (MIST) Price Forecast for 2028
In 2028, Milestone Pharmaceuticals Inc (MIST) is projected to reach an average price of $1.8757, with a high projection of $3.4588 and a low estimate of $0.2926. This indicates an +46.54% rise from the last price of $1.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.1298 | $0.2926 | $2.4498 | +66.39% |
| February, 2028 | $2.8531 | $1.3131 | $3.4588 | +122.90% |
| March, 2028 | $1.0628 | $1.1228 | $3.439 | -16.97% |
| April, 2028 | $0.8795 | $1.3395 | $1.2511 | -31.29% |
| May, 2028 | $1.8453 | $1.0778 | $1.5453 | +44.17% |
| June, 2028 | $1.632 | $1.6537 | $1.5745 | +27.50% |
| July, 2028 | $1.3487 | $1.5187 | $1.5612 | +5.37% |
| August, 2028 | $1.7646 | $1.7579 | $1.7563 | +37.86% |
| September, 2028 | $0.8713 | $0.8913 | $1.333 | -31.93% |
| October, 2028 | $0.968 | $1.0189 | $0.758 | -24.37% |
| November, 2028 | $0.5439 | $0.4147 | $0.2639 | -57.51% |
| December, 2028 | $1.2506 | $0.5131 | $0.8463 | -2.30% |
Milestone Pharmaceuticals Inc Stock (MIST) Price Forecast for 2029
The 2029 price forecast for Milestone Pharmaceuticals Inc Stock (MIST) is $7.2914 on average, with a high prediction of $14.57 and a low estimate of $0.0127. This represents an +469.64% increase from the previous price of $1.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6165 | $0.6953 | $0.5965 | -51.84% |
| February, 2029 | $0.7932 | $0.794 | $0.5732 | -38.03% |
| March, 2029 | $0.2899 | $0.5799 | $0.6871 | -77.35% |
| April, 2029 | $0.3366 | $0.3866 | $0.2391 | -73.70% |
| May, 2029 | $0.0725 | $0.3525 | $0.4941 | -94.34% |
| June, 2029 | $0.3908 | $0.12 | $0.6708 | -69.47% |
| July, 2029 | $0.9059 | $0.0667 | $0.7916 | -29.23% |
| August, 2029 | $0.7218 | $0.8818 | $0.8235 | -43.61% |
| September, 2029 | $0.4185 | $0.6485 | $0.561 | -67.31% |
| October, 2029 | $0.1244 | $0.4068 | $0.3552 | -90.28% |
| November, 2029 | $0.0211 | $0.0127 | $0.1665 | -98.35% |
| December, 2029 | $14.80 | $0.0544 | $14.57 | +1,056% |
Milestone Pharmaceuticals Inc Stock (MIST) Price Forecast for 2030
Milestone Pharmaceuticals Inc Stock (MIST) is expected to reach an average price of $16.86 in 2030, with a high forecast of $25.65 and a low forecast of $8.0659. This signifies an +1,217% surge from the last price of $1.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.57 | $12.53 | $13.03 | +804.04% |
| February, 2030 | $12.82 | $10.71 | $9.5352 | +901.19% |
| March, 2030 | $15.18 | $12.77 | $14.48 | +1,086% |
| April, 2030 | $8.122 | $11.93 | $14.86 | +534.53% |
| May, 2030 | $11.91 | $9.4703 | $11.33 | +830.76% |
| June, 2030 | $9.6472 | $10.78 | $11.73 | +653.68% |
| July, 2030 | $11.69 | $11.55 | $11.51 | +813.20% |
| August, 2030 | $13.88 | $13.05 | $12.77 | +984.17% |
| September, 2030 | $12.51 | $13.18 | $12.97 | +877.42% |
| October, 2030 | $7.5275 | $8.3208 | $9.9781 | +488.09% |
| November, 2030 | $11.97 | $8.0659 | $7.3726 | +835.23% |
| December, 2030 | $25.74 | $18.24 | $25.65 | +1,911% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):